Download PDF
Z Geburtshilfe Neonatol 2004; 208(3): 118-121
DOI: 10.1055/s-2004-819005
Fortbildung
© Georg Thieme Verlag KG Stuttgart · New York

Muttermilchernährung der sehr unreifen Frühgeborenen von HCMV-seropositiven Müttern

StellungnahmeBreast Feeding of Very Preterm Infants of HCMV-Seropositive MothersReview and StatementR. Goelz1 , K. Hamprecht2 , M. Vochem3 , J. Maschmann4 , C. P. Speer4 , G. Jahn2 , C. F. Poets1
  • 1Klinik für Kinderheilkunde und Jugendmedizin, Abt. Neonatologie, Universitätsklinikum Tübingen
  • 2Institut für Medizinische Virologie und Epidemiologie der Viruskrankheiten, Universitätsklinikum Tübingen
  • 3Klinik für Kinderheilkunde und Jugendmedizin, Abt. Neonatologie, Olgahospital,Stuttgart
  • 4Universitäts - Kinderklinik Würzburg
Further Information

Publication History

Eingereicht: 19.1.2004

Angenommen nach Überarbeitung: 30.3.2004

Publication Date:
30 June 2004 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Frühgeborene können durch virushaltige Muttermilch ihrer HCMV(Human Cytomegalovirus)-seropositiven Mütter infiziert werden. 96 % aller seropositiven Mütter reaktivieren das Virus in der Brustdrüse, 37 % der Frühgeborenen < 1500 g Geburtsgewicht infizieren sich, 49 % davon zeigen mindestens ein Symptom dieser Infektion. Zur Beantwortung der Frage, ob die Vorteile der Muttermilchernährung Frühgeborener die Nachteile einer eventuellen HCMV-Infektion aufwiegen, fehlt bislang Datenmaterial, das auch Langzeitergebnisse einschließt. Eine Inaktivierung des Virus in der Muttermilch kann nur die Pasteurisierung leisten, allerdings verbunden mit Qualitätsverlusten in der Zusammensetzung der Milch, deren Konsequenzen auch noch nicht hinreichend bekannt sind.

Die drei beteiligten Kliniken haben auf der Basis der aktuell verfügbaren Daten entschieden, weiterhin auch sehr kleine Frühgeborene mit supplementierter, jedoch nicht behandelter Muttermilch zu ernähren, allerdings nur mit Aufklärung und Einwilligung der Eltern.

Abkürzungen

HCMV:Humanes Cytomegalovirus

VLBW :Very low birth weight

ELBW:Extremly low birth weight

Abstract

Preterm infants can be infected with human cytomegalovirus (HCMV) transmitted via breast milk of their HCMV-seropositive mothers, 96 % of whom reactivate the virus during lactation. 38 % of exposed VLBW infants become infected, with 48 % of these developing at least one symptom. Whether priority should be given to the multiple advantages of breast milk feeding or to the avoidance of a possible HCMV infection by exclusive formula feeding still cannot be decided due to insufficient data on the long-term outcome of infected infants. Inactivation of HCMV in breast milk can be achieved safely only via heat treatment, but the clinical consequences resulting from the use of pasteurized breast milk are unknown. Given the above situation, the authors decided to continue breast-feeding of VLBW and ELBW infants in their units after obtaining informed parenteral consent, until data for an evidence-based decision become available.

Schlüsselwörter

Frühgeborene - HCMV - CMV - Muttermilch - Transmission - Infektion

Key words

Preterm - infant - HCMV - breast milk - transmission - infection

Literatur

  • 1 Prösch S, Döcke W D, Reinke P, Volk H D, Krüger D H. Human cytomegalovirus reactivation in bone-marrow-derived granulocyte/monocyte progenitor cells and mature monocytes.  Intervirology. 1999;  42 308-313
    CrossrefPubMedGoogle Scholar
  • 2 Reddehase M J, Podlech J, Grzimek N K. Mouse models of cytomegalovirus latency: Overview.  J Clin Virol. 2002;  25 Suppl 2 S23-26
    PubMedGoogle Scholar
  • 3 Hayes K; Danks D M, Gibas H, Jack I. Cytomegalovirus in human milk.  N Engl J Med. 1972;  287 177-8
    PubMedGoogle Scholar
  • 4 Stagno S, Reynolds D W, Pass R F, Alford C A. Breast milk and the risk of cytomegalovirus infection.  N Engl J Med. 1980;  302 1073-6
    CrossrefPubMedGoogle Scholar
  • 5 Dworsky M, Yow M, Stagno S, Pass R F, Alford C. Cytomegalovirus infection of breast milk and transmission in infancy.  Pediatrics. 1983;  72 295-9
    PubMedGoogle Scholar
  • 6 Ballard R A, Drew W L, Hufnagle K G, Riedel P A. Acquired cytomegalovirus infection in preterm infants.  Am J Dis Child. 1979;  133 482-5
    PubMedGoogle Scholar
  • 7 Yeager A S, Palumbo P E, Malachowski N, Ariagno R L, Stevenson D K. Sequelae of maternally derived cytomegalovirus infections in preterm infants.  J Pediatr. 1983;  102 918-22
    CrossrefPubMedGoogle Scholar
  • 8 Vochem M, Hamprecht K, Jahn G, Speer C P. Transmission of cytomegalovirus to preterm infants through breast milk.  Pediatr Infect Dis J. 1998;  17 53-8
    CrossrefPubMedGoogle Scholar
  • 9 Maschmann J, Hamprecht K, Dietz K, Jahn G, Speer C P. Cytomegalovirus infection of extremely low-birth weight infants via breast milk.  Clin Infect Dis. 2001;  33 1998-2003
    CrossrefPubMedGoogle Scholar
  • 10 Hamprecht K, Maschmann J, Vochem M, Dietz K, Speer C P, Jahn G. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding.  Lancet. 2001;  357 513-8
    CrossrefPubMedGoogle Scholar
  • 11 Hamprecht K, Vochem M, Baumeister A, Boniek M, Speer C P, Jahn G. Detection of cytomegaloviral DNA in human milk cells and cell free milk whey by nested PCR.  J Virol Methods. 1998;  70 167-76
    CrossrefPubMedGoogle Scholar
  • 12 Hamprecht K, Maschmann J, Vochem M, Speer C P, Jahn G. Transmission of cytomegalovirus to preterm infants by breastfeeding. Monographs in Virology. In: Prösch S, Cinatl J, Scholz M (eds) New Aspects of CMV-related Immunopathology. Basel; Karger 2003 Vol 24: 43-52
    Google Scholar
  • 13 Hamprecht K, Witzel S, Maschmann J, Dietz K, Baumeister A, Mikeler E, Goelz R, Speer C P, Jahn G. Rapid detection and quantification of cell free cytomegalovirus by a high-speed centrifugation-based microculture assay: comparison to longitudinally analyzed viral DNA load and pp67 late transcript during lactation.  J Clin Virol. 2003;  28 303-16
    CrossrefPubMedGoogle Scholar
  • 14 Kumar M L, Nankervis G A, Cooper A R, Gold E. Postnatally acquired cytomegalovirus infections in infants of CMV-excreting mothers.  J Pediatr. 1984;  104 669-73
    PubMedGoogle Scholar
  • 15 Paryani S G, Yeager A S, Hosford-Dunn H, Johnson S J, Malachowski N, Ariagno R L, Stevenson D K. Sequelae of acquired cytomegalovirus infection in premature and sick term infants.  J Pediatr. 1985;  107 451-6
    CrossrefPubMedGoogle Scholar
  • 16 Stagno S. Cytomegalovirus. In: Remington and Klein Infectious Disease of the Fetus and the Newborn Infant. 5th Edition 2001 W. B. Saunders Company 408
    Google Scholar
  • 17 Seibold-Weiger K, Vollmer B, Schmitz-Salue C, Hamprecht K, Speer C P. Sind bei postnatal über die Muttermilch CMV-infizierten Frühgeborenen langfristig Auswirkungen auf Entwicklung und Hörvermögen zu erwarten?.  Z Geburtsh Neonatol. 2001;  205 S3
    PubMedGoogle Scholar
  • 18 Lucas A, Cole T J. Breast milk and neonatal necrotising enterocolitis.  Lancet. 1990;  336 1519-23
    Google Scholar
  • 19 McGuire W, Anthony M Y. Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review.  Arch Dis Child Fetal Neonatal Ed. 2003;  88 F11-4
    PubMedGoogle Scholar
  • 20 Hylander M A, Strobino D M, Dhanireddy R. Human milk feedings and infection among very low birth weight infants.  Pediatrics. 1998;  102 E38
    CrossrefPubMedGoogle Scholar
  • 21 Schanler R J, Shulman R J, Lau C. Feeding Strategies for Premature Infants: Beneficial Outcomes of Feeding Fortified Human Milk Versus Preterm Formula.  Pediatrics. 1999;  103 1150-7
    CrossrefPubMedGoogle Scholar
  • 22 Furman L, Taylor G, Minich N, Hack M. The effect of maternal milk on neonatal morbidity of very-low-birth-weight infants.  Arch Pediatr Adolesc Med. 2003;  157 66-71
    CrossrefPubMedGoogle Scholar
  • 23 Lucas A, Morley R, Cole T J, Lister G, Leeson-Payne C. Breast milk and subsequent intelligence quotient in children born preterm.  Lancet. 1992;  339 261-4
    CrossrefPubMedGoogle Scholar
  • 24 Wagner C L, Wagner M T. The breast or the bottle.  Clin Perinatol. 1999;  26 505-25
    PubMedGoogle Scholar
  • 25 Srivastava M D, Srivastava A, Brouhard B, Saneto R, Groh-Wargo S, Kubit J. Cytokines in human milk.  Res Commun Mol Pathol Pharmacol. 1996;  93 259-87
    PubMedGoogle Scholar
  • 26 Garofalo R G, Goldman A S. Expression of functional immunomodulatory and anti-inflammatory factors in human milk. Clin Perinatol 1999: 361-78
    Google Scholar
  • 27 Elmlinger M W, Grund R, Buck M, Wollmann H A, Feist N, Weber M M, Speer C P, Ranke M B. Limited proteolysis of the IGF-binding protein-2 (IGFBP-2) by a specific serine protease activity in early breast milk.  Pediatr Res. 1999;  46 76-81
    PubMedGoogle Scholar
  • 28 Siafakas C G, Anatolitou F, Fusunyan R D, Walker W A, Sanderson I R. Vascular endothelial growth factor (VEGF) is present in human breast milk and its receptor is present on intestinal epithelial cells.  Pediatr Res. 1999;  45 652-7
    PubMedGoogle Scholar
  • 29 Buescher E S, McWilliams-Koeppen P. Soluble tumor necrosis factor alpha receptors in human colostrumand milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.  Pediatr Res. 1998;  44 37-42
    PubMedGoogle Scholar
  • 30 Schanler R J, Hurst N M, Lau C. The use of human milk and breast feeding in premature infants.  Clin Perinatol. 1999;  26 379-98
    PubMedGoogle Scholar
  • 31 Toschke A M, Vignerova J, Lhotska L, Osancova K, Koletzko B, von Kries R. Overweight and obesity in six to forteen year old czech children in 1991: Protective effect of breast-feeding.  J Pediatr. 2002;  141 764-9
    CrossrefPubMedGoogle Scholar
  • 32 Goldblum R M, Dill C W, Albrecht T B, Alford E S, Garza C, Goldman A S. Rapid high-temperature treatment of human milk.  J Pediatr. 1984;  104 380-5
    PubMedGoogle Scholar
  • 33 Ford J E, Law B A, Valerie M E, Marshall B, Reiter B. Influence of the heat treatment of human milk on some of its protective constituents.  J Pediatr. 1977;  90 29-35
    PubMedGoogle Scholar
  • 34 Welsh J K, Arsenakis M, Coelen R J, May J T. Effects of antiviral lipids, heat and freezing on the activity of viruses in human milk.  J Infect Dis. 1979;  140 322-328
    PubMedGoogle Scholar
  • 35 Dworsky M, Stagno S, Pass R F, Cassady G, Alford C. Persistence of cytomegalovirus in human milk after storage.  J Pediatr. 1982;  101 440-3
    PubMedGoogle Scholar
  • 36 Evans T J, Ryley H C, Neale L M, Dodge J A, Lewarne V M. Effect of storage and heat on antimicrobial proteins in human milk.  Arch Dis Child. 1978;  53 239-41
    CrossrefPubMedGoogle Scholar
  • 37 Liebherr M, Lewiston J, Asquith M T, Olds-Arroyo L, Sunshine P. Alterations of lymphocytes and of antibody content of human milk after processing.  J Pediatr. 1977;  91 897-900
    PubMedGoogle Scholar
  • 38 Hamprecht K, Maschmann J, Müller D, Dietz K, Besenthal I, Goelz R, Middeldorp J M, Speer C P, Jahn G. Cytomegalovirus inactivation in breast milk: reassessment of pasteurisation and freeze-thawing. Pediatr Res 2004, in press
    Google Scholar
  • 39 Maschmann J, Speer C P, Jahn G, Hamprecht K. Inactivation of cytomegalovirus (CMV) in breast milk.  Pediatr Res. 1999;  45 924
    PubMedGoogle Scholar
  • 40 Maschmann J, Speer C P, Jahn G, Hamprecht K. Freezing of breast milk does not prevent cytomegalovirus (CMV) infection in premature infants: a case report and results from spiking experiments.  J Matern Fetal Neonatal Med. 2002;  11 (Supp 1) 110
    PubMedGoogle Scholar
  • 41 Maschmann J, Hamprecht K, Weissbrich B, Dietz K, Jahn G, Speer C P. Freeze-thawing of breast milk does not prevent cytomegalovirus transmission to preterm infants. Submitted. 
    Google Scholar
  • 42 Lawrence R M, Lawrence R A. Given the benefits of breastfeeding, what contra-indications exist?.  Pediatr Clin North Am. 2001;  48 235-51
    CrossrefPubMedGoogle Scholar
  • 43 Sharland M, Khare M, Bedford-Russell A. Prevention of postnatal cytomegalovirus infection in preterm infants.  Arch Dis Child Fetal Neonatal Ed. 2002;  86 F140
    PubMedGoogle Scholar
  • 44 Yasuda A, Kimura H, Hayakawa M, Ohshiro M, Kato Y, Matsuura O, Suzuki C, Morishima T. Evaluation of cytomegalovirus infections transmitted via breast milk in preterm infants with a real-time polymerase chain reaction assay.  Pediatrics. 2003;  111 1333-6
    CrossrefPubMedGoogle Scholar
  • 45 American Academy of Pediatrics and Work Group on Breastfeeding. Breastfeeding and the use of human milk (RE9729). Pediatrics 1997 100: 1035-9
    Google Scholar
  • 46 Bryant P, Morley C, Garland S, Curtis N. Cytomegalovirus transmission from breast milk in premature babies: does it matter.  Arch Dis Child Fetal Neonatal Ed. 2002;  57 F75-77 (Review)
    PubMedGoogle Scholar
  • 47 Zwiauer K, Deutsch J, Goriup U e a. Konsensuspapier der Ernährungskommission der Österreichischen Gesellschaft für Kinder- und Jugendheilkunde. Prävention von Muttermilch-mediierten CMV-Infektionen bei Frühgeborenen.  Monatsschrift Kinderheilkunde. 2003;  151 1346-7
    PubMedGoogle Scholar
  • 48 Richter D, Hampl W, Pohlandt F. Vertical transmission of cytomegalovirus, most probably by breast milk, to an infant with Wiskott-Aldrich syndrome with fatal outcome.  Eur J Pediatr. 1997;  156 854-5
    CrossrefPubMedGoogle Scholar

Dr. R. Goelz

Abteilung Neonatologie der Universitätsklinik für Kinderheilkunde und Jugendmedizin

Calwerstrasse 7

D-72076 Tübingen

Phone: 07071/29 80895

Fax: 07071 - 295923

Email: rrgoelz@med.uni-tuebingen.de

      >